Copeptin in aneurysmal subarachnoid hemorrhage

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 01 Jan 2012 English Publisher:Springer Science and Business Media LLCJournal:Critical Care, volume 16, page 103 (issn: 1364-8535,

Copyright policy )

Authors: Tamargo, Rafael J;

doi: 10.1186/cc10594

pmid: 22236394

pmc: PMC3396223

Copeptin in aneurysmal subarachnoid hemorrhage

- Summary
- Subjects
- Metrics

Abstract

Copeptin is a peptide derived from pre-provasospression along with arginine vasospressin. In the setting of aneurysmal subarachnoid hemorrhage (SAH), elevated serum copeptin levels correlate with vasospasm, inpatient mortality, mortality at 1 year, and poor functional outcome at 1 year. The potential role of serum copeptin levels in the management of patients with aneurysmal SAH is promising and should be explored further.

Related Organizations

John Hopkins University School of Medecine
United States
Johns Hopkins Medicine
United States
Johns Hopkins University Sch of Medicine
United States
Johns Hopkins University School of Medicine
United States
Johns Hopkins Hospital
United States

Keywords

Male, Commentary, Glycopeptides, Humans, Female, Subarachnoid Hemorrhage

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	7
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average